 <p><b>Orphan Drug COVID-19 Mitigation Act of 2022</b></p> <p>This bill extends by 180 days the relevant periods of market exclusivity for drugs for rare diseases or conditions (i.e., orphan drugs) for which applications were submitted during the COVID-19 emergency period. </p>